Bio-Techne To Acquire Exosome Diagnostics, Inc.
Bio-Techne To Acquire Exosome Diagnostics, Inc. PR Newswire MINNEAPOLIS and WALTHAM, Mass., June 25, 2018 MINNEAPOLIS and WALTHAM, Mass. […]
Bio-Techne To Acquire Exosome Diagnostics, Inc. PR Newswire MINNEAPOLIS and WALTHAM, Mass., June 25, 2018 MINNEAPOLIS and WALTHAM, Mass. […]
Petróleo Brasileiro S.A. or Petrobras PBR recently lost a wage lawsuit when Brazil’s Labor Court voted in favor of the workers of Petrobras seeking higher wages. This is notably the biggest lawsuit that the company has faced in the Brazil’s Labor Court, which is expected to cost the company around 17 billion reals or 4.5 billion in U.S […]
Strong housing demand and lack of competition in the luxury new home market are favoring Toll Brothers Inc TOL . Overall fundamentals of the housing market were strong in 2017 and are expected to improve further in the rest of 2018. Steady job and wage growth, recovering economy, moderate home price gains, rising rentals, rapidly increasing household formation and a limited supply of inventory indicate consistent strong demand through 2018. […]
Atlas Travel Announces Flagship Acquisition PR Newswire MARLBOROUGH, Mass., June 25, 2018 MARLBOROUGH, Mass. , June 25, 2018 /PRNewswire/ — On Tuesday May 22 nd , locally-based Atlas Travel expanded its leisure expertise through the acquisition of Flagship Travel. […]
On Jun 22, we issued an updated research report on IDEXX Laboratories, Inc. IDXX . The company’s robust worldwide commercial capabilities and best-in-class products including the next-generation chemistry analyzer, Catalyst One, are key growth drivers over the near term […]
Merck & Co., Inc MRK presented new data from two studies, evaluating its type II diabetes drug Januvia (sitagliptin) as a treatment option on type II diabetes patients, who initiate insulin therapy and those with a mild renal impairment. The CompoSIT-I study showed higher reduction of blood glucose level in patients, who initiated insulin dosage while continuing treatment with Januvia compared with those who discontinued Januvia. The CompoSIT-R trial evaluated subjects with mild renal impairment, who were not adequately controlled by metformin. […]
On Jun 22, 2018, Molina Healthcare, Inc. MOH hit a 52 week high of $103.27 but ended the trading session at $101.48. […]
Lockheed Martin Corp. ’s LMT business segment, Aeronautics, recently clinched a foreign military sales (FMS) contract for manufacturing 16 F-16 V Block 70 aircraft. […]
Paychex Inc. PAYX is set to report fourth-quarter fiscal 2018 results on Jun 27 before the bell. We expect revenues of Payroll service and Human Resource Services (HRS) to increase in the to-be-reported quarter. […]
Trump’s protectionist stance on trade led to sluggish trading on Wall Street. This is especially true, as a series of tariff talks between the United States and its other major allies are intensifying fears of a trade war and could even trigger a global recession. […]
Roche Holdings RHHBY announced that the phase III study, IMpower133, on immuno-oncology drug, Tecentriq, met its co-primary endpoints of overall survival (OS) and progression-free survival (PFS) at its first interim analysis for the indication of extensive-stage small cell lung cancer (ES-SCLC). The study enrolled 403 people who were randomised equally (1: 1 ) to receive either Tecentriq in combination with carboplatin and etoposide (Arm A), or placebo in combination with carboplatin and etoposide (Arm B, control arm). The results of the study showed that initial (first-line) treatment with the combination of Tecentriq and chemotherapy (carboplatin and etoposide) enabled patients with ES-SCLC live significantly longer compared to chemotherapy alone. […]
Eli Lilly & Company LLY has received a favorable ruling from a U.S. district court in a patent dispute against India’s generic drugmaker Dr. […]
Arthur J. Gallagher & Co. AJG recently acquired Dicentra Pension Services, LLC […]
Shares of FedEx Corporation FDX declined 6.2% to $241.77 post the earnings release on Jun 19, despite reporting better-than-expected revenues and earnings per share in the fourth quarter of fiscal 2018. Reasons Behind the Stock’s Plunge The escalating fears of a trade war hampering the free flow of goods between countries are the main reasons behind the stock’s dismal performance. […]
Medtronic plc MDT continues to hit headlines with its steady strategic developments. Recently, the company caught investors’ attention on the receipt of expanded 510(k) clearances for the company’s Kyphon HV-R Bone Cement for fixation of pathological fractures of the sacral vertebral body. […]
Aetna Better HealthSM of Kansas, a subsidiary of Aetna Inc. AET has been awarded a Medicaid managed care contract by the state itself. […]
Enphase Energy, Inc. ENPH was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session […]
Value investing is always a very popular strategy, and for good reason. After all, who doesn’t want to find stocks that have low PEs, solid outlooks, and decent dividends? […]
Investors looking for stocks in the Chemical – Plastic sector might want to consider either Westlake Chemical (WLK) or PolyOne (POL). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look […]
Investors focused on the Business Services space have likely heard of Insperity (NSP), but is the stock performing well in comparison to the rest of its sector peers? By taking a look at the stock's year-to-date performance in comparison to its Business Services peers, we might be able to answer that question. […]
Copyright © 2024 | MH Magazine WordPress Theme by MH Themes